SRSF2 and chronic myelomonocytic leukemia: During the past years, several studies have reported recurrent gene mutations in CMML, being mutations in TET2 (50-60%), ASXL1 (40-50%) and SRSF2 (40-50%) the most frequent [7, 9, 10].